Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
5
(5 Reviews)
|
(3 Publications)
Rabbit Recombinant Monoclonal SPIKE antibody. Suitable for Dot, ELISA, WB, ICC/IF, Flow Cyt and reacts with SARS-CoV-2 samples. Cited in 3 publications.
View Alternative Names
2, S, Spike glycoprotein, S glycoprotein, E2, Peplomer protein
- ELISA
Lab
ELISA - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (AB283942)
Indirect ELISA showing primary antibody ab283942 binding to recombinant human coronavirus SARS-CoV-2 (Omicron variant) Spike Glycoprotein S1; SARS-CoV-2 (Omicron variant) Spike Glycoprotein RBD; SARS-CoV-2 Omicron variant Spike protein (GCN4-IZ) His tag; Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera).
Plates were coated with recombinant human coronavirus SARS-CoV-2 (Omicron variant) Spike Glycoprotein S1; SARS-CoV-2 (Omicron variant) Spike Glycoprotein RBD; SARS-CoV-2 Omicron variant Spike protein (GCN4-IZ) His tag; Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera) at 1000 ng/mL. Binding of ab283942 was assessed in a serial dilution range 0 - 1000 ng/mL.
Binding was detected usingAlkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at 1/2500 dilution.
Substrate Solution : p-nitrophenyl phosphate(PNPP)
- ELISA
Supplier Data
ELISA - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (AB283942)
Indirect ELISA showing primary antibody ab283942 binding to the antigen ab272105 (recombinant human coronavirus SARS-CoV-2 spike glycoprotein S1 (Fc Chimera)). Plates were coated with recombinant human coronavirus SARS-CoV-2 spike glycoprotein S1 (Fc Chimera, ab272105) and recombinant human coronavirus SARS spike glycoprotein (Tagged, ab270844) at 1000 ng/ml. Binding of ab283942 was assessed in a serial dilution range 0.04- 100 ng/mL (a 3-fold serial dilution).
Binding was detected using pre-adsorbed secondary antibody, goat anti-rabbit IgG H&L (HRP, ab97080) at 1/2000 dilution.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (AB283942)
Immunocytochemistry/ Immunofluorescence analysis of HEK-293T transfected with a Spike-SARS-CoV2 expression vector labeling SARS-CoV-2 Spike Glycoprotein S1 with ab283942 at 1/500 dilution followed by ab150081 AlexaFluor®488 Goat anti-Rabbit secondary (green) at 1/1000 dilution. The counterstain was Anti-FLAG mouse monoclonal antibody at 1/500 dilution followed by ab150120 AlexaFluor®594 Goat anti-Mouse secondary(red) at 1/1000 dilution. Cells were fixed with 100% methanol and permeabilised with 0.1% TritonX-100. Nuclear counterstain was DAPI. Confocal image showing the antibody co-stain with Flag in HEK-293T cells transfected with a Spike-SARS-CoV2 expression vector containing a flag tag. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- Flow Cyt
Lab
Flow Cytometry - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (AB283942)
Flow Cytometry analysis of HEK-293T (Human embryonic kidney epithelial cell) cells transfected with a Spike SARS-CoV-1 (Left) or Spike SARS-CoV-2 (Right) expression vector labeling SARS-CoV-2 Spike Glycoprotein S1 with ab283942 at 1/500 dilution followed by ab150081 AlexaFluor®488 Goat anti-Rabbit secondary (green) at 1/2000 dilution. Cells were fixed with 2% Paraformaldehyde and permeabilised with 0.1% Tween-20. Cells were surface stained with ab283942. Then fixed with 2% PFA for 10min followed by intracellularly stained with anti-Flag tag conjugated to BV421. No cross-reactivity with Spike SARS-CoV-1.
- WB
Supplier Data
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (AB283942)
Lane 1 : Red – loading control Mouse anti-6x His tag antibody (ab18184) observed at 135 kDa
Lanes 2 : Green – ab283942 observed at 135 kDa
ab283942 was shown to bind specifically to SARS-CoV-2 spike glycoprotein S1 in Western blot. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) at 1/20000 dilution.
Blocking buffer : 3% milk in TBS-0.1% Tween® 20 (TBS-T)
All lanes:
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (ab283942) at 1/1000 dilution
All lanes:
Western blot - Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Active) (<a href='/en-us/products/proteins-peptides/recombinant-human-coronavirus-sars-cov-2-spike-glycoprotein-s1-active-ab273068'>ab273068</a>) at 0.2 µg
Observed band size: 135 kDa
false
- WB
AbReview79645****
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (AB283942)
All lanes:
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (ab283942) at 1 µg/mL
Lane 1:
Precision Plus Protein™ Dual Color Standard
Lane 2:
CaCo2 Uninfected whole cell lysate, at 40 µg
Lane 3:
CaCo2 infected with SARS-CoV-2 whole cell lysate at 40 µg
Lane 4:
CaCo2 infected with CoV-NL63 whole cell lysate at 40 µg
Lane 5:
CaCo2 infected with CoV-OC463 whole cell lysate at 40 µg
Lane 6:
recombinant SARS CoV-2 spike protein + twin strep tag at 75 ng
Lane 7:
A549 WT whole cell lysate at 15 µg
Secondary
All lanes:
LiCor goat anti-rabbit IRDye; 800CW
false
This image is courtesy of an Abreview submitted by Nicola Goodman
- WB
Supplier Data
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (AB283942)
ab283942 was shown to bind specifically to SARS-CoV-2 spike glycoprotein S1 in Western blot. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed (ab216775) and Donkey anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216779) at 1/20000 dilution.
Blocking buffer : 3% milk in TBS-0.1% Tween® 20 (TBS-T)
Lanes 1 - 2:
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (ab283942) at 1/20000 dilution
Lanes 3 - 4:
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (ab283942) at 1/1000 dilution
Lanes 1 and 3:
Expi293 cells transfected with SARS-CoV2 3xFlag Spike Protein at 20 µg
Lanes 2 and 4:
Expi293 cells transfected with SARS-CoV1 3xFlag Spike Protein at 20 µg
Secondary
All lanes:
Western blot - Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/donkey-goat-igg-h-l-irdye-800cw-preadsorbed-ab216775'>ab216775</a>) at 1/20000 dilution
Observed band size: 200 kDa
false
- Dot
Lab
Dot Blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] (AB283942)
Dot blot analysis of Recombinant Human coronavirus SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein S1 (ab290828) (Lane 1), Recombinant Human coronavirus SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein S1 RBD protein (ab290829) (Lane 2), Recombinant Human coronavirus SARS-CoV-2 (B.1.1.529/Omicron) Spike protein (Lane 3) and Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (ab272105) (Lane 4) labelling SARS-CoV-2 Spike Glycoprotein S1 with ab283942 at a dilution of 1/1000. Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG was used as the secondary antibody at a dilution of 1/2000. This antibody reacts with Omicron (B.1.1.529) variant. Blocking and dilution buffer : 5% NFDM/TBST. Exposure time : 180 seconds.
Related conjugates and formulations (7)
-
Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] - Human IgG1 (Chimeric)
-
Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] - Chicken IgY (Chimeric)
-
Anti-SARS-CoV-2 S antibody [EPR24852-116] - Human IgG1 (Chimeric) - BSA and Azide free
-
Anti-SARS-CoV-2 S antibody [EPR24852-116] - Chicken IgY (Chimeric) - BSA and Azide free
-
Anti-SARS-CoV-2 Spike Glycoprotein S1 [EPR24852-116] - Mouse IgG1 (Chimeric)
-
Anti-SARS-CoV-2 Spike Glycoprotein S1 [EPR24852-116] - Mouse IgG1 (Chimeric) - BSA and Azide free
-
Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The spike glycoprotein S1 mediates the fusion of the viral and cellular membranes which is necessary for viral entry. It forms part of a larger trimeric complex comprising S1 and S2 subunits. This complex undergoes conformational changes that drive the membrane fusion process. The glycoprotein contains multiple glycosylation sites which help shield the virus from the host immune response. The proper function and presentation of this glycoprotein are critical for efficient viral spread and infection establishment.
Pathways
The spike glycoprotein S1 is integral to the viral infection pathway and host immune evasion. It interacts with the renin-angiotensin system by binding to the ACE2 receptor disrupting normal receptor activity. This interaction not only facilitates viral entry but also impacts the homeostatic functions typically mediated by ACE2 which include blood pressure regulation. Additionally the spike protein is involved in downstream activation of immune signaling pathways including those related to inflammation and cytokine production which may involve proteins such as IL-6.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Cells 13: PubMed39513874
2024
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 20:2238-2254 PubMed38842055
2024
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutics 14: PubMed36297481
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com